BNTX
<% (signals.list.current.rate).substr(0,7) %>
<% signal.analyst %>
Last Updated: Jun 24, 2026 03:29:25 PM (GMT)
BNTX: The current market price is 90.46, reflecting a percentage change of +0.27% from the previous price.
Support and Resistance Levels Current support levels are at 89.4, 88.95, and 88.1. Resistance levels are situated at 90.7, 91.55, and 92. The pivot point is 90.25.
Indicators RSI is currently at 45.78, with a history indicating declines. ATR is at 0.28246, suggesting moderate volatility. The MACD shows a current value of -0.13742. The Parabolic SAR indicates a current level of 89.09, consistent with downtrend support. The 50-day SMA is 90.334, while the 200-day EMA is 90.992.
Market Sentiment The current price is below the pivot point (90.25), indicating a bearish outlook supported by the downward trend in RSI and MACD.
BNTX Signals & Technical Analysis
Market Sentiment
Trend Indicators
Oscillators
Moving Averages
Pivot
About (BNTX) BioNTech SE
Company Background
BioNTech SE, a German biotechnology company, is a pioneer in the development of personalized immunotherapies for the treatment of cancer and infectious diseases. Founded in 2008, BioNTech has rapidly advanced its innovative mRNA technology platform, which garnered international attention during the COVID-19 pandemic with the development of its highly effective vaccine in collaboration with Pfizer. Headquartered in Mainz, Germany, the company focuses on creating transformative therapies that harness the body’s immune system to fight diseases more effectively.Market Position
As a leader in the biotechnology sector, BioNTech is positioned at the forefront of the global race to develop targeted therapies and vaccines. The company’s pioneering work in mRNA technology has established it as a key player in the biotech industry. BioNTech’s diverse product pipeline includes therapies for various cancers and infectious diseases, with several candidates in late-stage clinical trials. The company's market capitalization and strong partnerships with pharmaceutical leaders underscore its significant role in advancing medical science and improving patient outcomes.Key Financial Highlights
BioNTech’s financial performance has witnessed remarkable growth due to the unprecedented demand for its COVID-19 vaccine. As of the most recent fiscal reports, the company has generated substantial revenues, allowing for increased investments in research and development. This financial strength enables BioNTech to explore new opportunities in biotechnology, including its promising pipeline of personalized cancer therapies and next-generation vaccines. Analysts anticipate continued growth, driven by ongoing innovation and strategic collaborations, positioning BioNTech favorably within the competitive landscape of biotechnology.Industry Highlights
The biotechnology industry is experiencing robust growth, propelled by advancements in genetic research and technology. BioNTech is at the cutting edge of this evolution, leveraging its mRNA expertise not only for vaccines but also for therapeutic applications. With a strong focus on personalized medicine and immunotherapy, BioNTech is well-equipped to meet the challenges of modern healthcare. The company's ongoing commitment to scientific excellence and collaborative partnerships positions it as a key contributor to the future of medicine, enhancing its long-term prospects as a prominent player in the biotechnology market.How to Buy or Trade BioNTech SE Stock (BNTX) with AvaTrade
Trading or investing in BioNTech SE stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol BNTX, which represents BioNTech SE. Before placing a trade, review the live BioNTech SE share price, market trend, spread, leverage options, and recent market news that could impact the stock price.
The next step is deciding whether you want to buy or sell BioNTech SE stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including BioNTech SE earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.
Related Stocks
Sidebar rates
- <% signal.pair %>
<% signals.active.Current.rate.substr(0,7) %>
